Top

Annals of Hematology

Published in:

01-01-2013 | Letter to the Editor

Isolated central nervous system relapse presenting as myeloid sarcoma of acute myeloid leukemia after allogeneic peripheral blood stem cell transplantation

Authors: Shih-Feng Cho, Ta-Chih Liu, Chao-Sung Chang

Published in: Annals of Hematology | Issue 1/2013

Excerpt

Dear Editor, …

Pileri SA, Ascani S, Cox MC et al (2007) Myeloid sarcoma: clinicopathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia 21(2):340–350. doi:10.1038/sj.leu.2404491 PubMedCrossRef

Maeng H, Cheong JW, Lee ST et al (2004) Isolated extramedullary relapse of acute myelogenous leukemia as a uterine granulocytic sarcoma in an allogeneic hematopoietic stem cell transplantation recipient. Yonsei Med J 45(2):330–333PubMed

Solh M, DeFor TE, Weisdorf DJ, Kaufman DS (2012) Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant 18(1):106–112. doi:10.1016/j.bbmt.2011.05.023 PubMedCrossRef

Oshima K, Kanda Y, Yamashita T et al (2008) Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 14(10):1100–1107. doi:10.1016/j.bbmt.2008.07.002 PubMedCrossRef

Cunningham I (2006) Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma 47(9):1754–1767. doi:10.1080/10428190600632857 PubMedCrossRef

Lee KH, Lee JH, Choi SJ et al (2003) Bone marrow vs. extra-medullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant 32(8):835–842. doi:10.1038/sj.bmt.17042231704223 PubMedCrossRef

Chong G, Byrnes G, Szer J, Grigg A (2000) Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy. Bone Marrow Transplant 26(9):1011–1015. doi:10.1038/sj.bmt.1702659 PubMedCrossRef

Byrd JC, Edenfield WJ, Shields DJ, Dawson NA (1995) Extramedullary myeloid cell tumors in acute non-lymphocytic leukemia: a clinical review. J Clin Oncol 13(7):1800–1816PubMed

Markoc F, Bozdogan N, Yukruk FA, Gumuc EB, Akdur NC (2010) Granulocytic sarcomas: difficulties in diagnosis. Tumori 96(1):149–153PubMed

10.

Khan F, Agarwal A, Agrawal S (2004) Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 34(1):1–12. doi:10.1038/sj.bmt.17045251704525 PubMedCrossRef

11.

Koc Y, Miller KB, Schenkein DP, Daoust P, Sprague K, Berkman E (1999) Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation. Cancer 85(3):608–615. doi:10.1002/(SICI)1097-0142(19990201)85:3<608::AID-CNCR11>3.0.CO;2-5 PubMedCrossRef

12.

Frassoni F, Barrett AJ, Granena A et al (1988) Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases. Br J Haematol 70(3):317–332PubMedCrossRef

Title: Isolated central nervous system relapse presenting as myeloid sarcoma of acute myeloid leukemia after allogeneic peripheral blood stem cell transplantation
Authors: Shih-Feng Cho
Ta-Chih Liu
Chao-Sung Chang
Publication date: 01-01-2013
Publisher: Springer-Verlag
Published in: Annals of Hematology / Issue 1/2013
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-012-1540-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

A case of Langerhans cell histiocytosis following acute basophilic leukemia

Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study

Bendamustine salvage for the treatment of relapsed Hodgkin’s lymphoma after allogeneic bone marrow transplantation

Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia

Interrelationship and expression profiling of cyclooxygenase and angiogenic factors in Indian patients with multiple myeloma

Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials